SF30 Amendment 0001.pdf

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment your desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE

2. AMENDMENT/MODIFICATION NO. 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQ. NO. 5. PROJECT NO. (If applicable)

7. ADMINISTERED BY (If other than Item 6) CODE

STANDARD FORM 30 (REV. 10-83)

Prescribed by GSA FAR (48 CFR) 53.243

FACILITY CODE

9A. AMENDMENT OF SOLICITATION

NO.

9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NO.

10B. DATED (SEE ITEM 13)

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended, is not extended.

12. ACCOUNTING AND APPROPRIATION DATA (If required) copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO.

IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15C. DATE SIGNED

15A. NAME AND TITLE OF SIGNER (Type or print)

16C. DATE SIGNED

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PAGE OF PAGES

6. ISSUED BY CODE

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code) (X)

CODE

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

NSN 7540-01-152-8070

Previous edition unusable

W81K00

The purpose of this amendment is to address industry generated questions and answers, as well as to revise the Schedule of Supplies/Services, attachment three (3) of the Combined Synopsis and Solicitation.

POC: J. Chris Finkenstadt, john.c.finkenstadt2.civ@health.mil

W40M USA HLTH CONTRACTING ACT

REGIONAL HEALTH CONTRACT OFF CENTRAL

2539 GARDEN AVENUE

FT SAM HOUSTON TX 78234-0000

See Item 6

0011942761

W81K0023R0034

1 5

06/27/2023

06/26/2023

W81K0023R0034 Amendment 0001

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

The following have been added by full text:

CONTINUATION PAGE

Industry Generated Questions and Answers

1. Q: " Diagnostica Stago, Inc. would like to respond, but the RFP is written in such a way where we will not meet the minimum specs.

-Attachment 3, page 52 of 82 & 53 of 82, specifically list Reagent and quanties specific for the Siemens CA-660 instrument and requesting price for these specific items. Only Siemens can respond to this.

-Requirements on page 55 of 82 oThe instrument size is almost exactly the size of the Werfen IL 350, eliminating our slightly larger Compact MAX.

oBid States must be capable of performing Factor Parallelism, which is only used when performing specialized testing of Factor Deficient Plasmas. These tests are not part of the menu on page 82 of 82 and based upon the size of your lab, is highly unlikely you will ever perform. The instrument size eliminates the Compact MAX which can perform these tests.

o“Clot Curves” are not FDA approved and are used to visualize why the Analyzer did not produce a reportable result. Diagnostica Stago, Inc. uses Mechanical clot detection to provide an accurate result, therefore not needing clot curves to imply why you did not.

Without a modification, we can not be “Technically Acceptable.” Please let me know your thoughts?"

Thank you for your consideration and the opportunity to participate in this solicitation. Have a great weekend!"

A: "1. See the revised Schedule of Supplies description, as page 82 has the annual amount of each coagulation test that the lab foresees. Estimation for reagents and supplies should be based off these numbers. 2. Due to the limitation of our counter space, we cannot accept larger size analyzers at this time.

3. It is preferred the analyzer to have the capability to perform specialized testing but not required. 4. We understand different vendors use their own terminologies in terms of clot detection technology, what we need is a visual display of the activity that occurs during a clotting assay. Please provide your capabilities IAW the RFQ and they will be evaluated IAW the RFQ."

ATTACHMENT 3

REVISED SCHEDULE OF SUPPLIES/SERVICES

SCHEDULE OF SUPPLIES/SERVICES

Line No. Description Qty Unit of Issue

Unit Price Total Price

Base Year: FY24 Cost Per Reportable Result for Coagulation, aPTT test IAW Performance Work Statement; IAW Period of Performance: 01 October 2023- 30 September 2024 10 EA

Base Year: FY24 Cost Per Reportable Result for Coagulation, D-Dimer test IAW Performance Work Statement; Period of Performance: 01 October 2023- 30 September 2024 13 EA

Base Year: FY24 Cost Per Reportable Result for Coagulation, Prothrombin time test IAW Performance Work Statement; Period of Performance: 01 October 2023- 30 September

10 EA

Option Year 1: FY25 Cost Per Reportable Result for Coagulation, aPTT test IAW Performance Work Statement; Period of Performance: 01 October 2024- 30 September 2025 10 EA

Option Year 1: FY25 Cost Per Reportable Result for Coagulation, D-Dimer test IAW Performance Work Statement; Period of Performance: 01 October 2024- 30 September 2025 13 EA

Option Year 1: FY25 Cost Per Reportable Result for Coagulation; Prothrombin time test IAW Performance Work Statement; Period of Performance: 01 October 2024- 30 September

10 EA

Option Year 2: FY26 Cost Per Reportable Result for Coagulation; aPTT test IAW Performance Work Statement; Period of Performance: 01 October 2025- 30 September 2026 10 EA

Option Year 2: FY26 Cost Per Reportable Result for Coagulation; D-Dimer test IAW Performance Work Statement; Period of Performance: 01 October 2025- 30 September 2026 13 EA

Option Year 2: FY26 Cost Per Reportable Result for Coagulation; Prothrombin time test IAW Performance Work Statement; IAW Period of Performance: 01 October 2025- 30 September

10 EA

Option Year 3: FY27 Cost Per Reportable Result for Coagulation; aPTT test IAW Performance Work Statement; Period of Performance: 01 October 2026- 30 September 2027 10 EA

Option Year 3: FY27 Cost Per Reportable Result for Coagulation; D-Dimer test IAW Performance Work Statement; Period of Performance: 01 October 2026- 30 September 2027 13 EA

Option Year 3: FY27 Cost Per Reportable Result for Coagulation; Prothrombin time test IAW Performance Work Statement; Period of Performance: 01 October 2026- 30 September

10 EA

Option Year 4: FY28 Cost Per Reportable Result for Coagulation; aPTT test IAW Performance Work Statement; Period of Performance: 01 October 2027- 30 September 2028 10 EA

Option Year 4: FY28 Cost Per Reportable Result for Coagulation; D-Dimer test IAW Performance Work Statement; Period of Performance: 01 October 2027- 30 September 2028 13 EA

Option Year 4: FY28 Cost Per Reportable Result for Coagulation; Prothrombin time test IAW Performance Work Statement; Period of Performance: 01 October 2027- 30 September

10 EA

Firm Fixed Price (FFP)

Period of Performance duration will be from 01 October 2023 to 30 September 2024 plus four option years.

Base Year: 01 October 2023 thru 30 September 2024

Option Year 1: 01 October 2024 thru 30 September 2025

Option Year 2: 01 October 2025 thru 30 September 2026

Option Year 3: 01 October 2026 thru 30 September 2027

Option Year 4: 01 October 2027 thru 30 September 2028

Place of Performance/Delivery IAW the Performance Work Statement at the following:

W2NK MEDDAC Supply Acct

7606 Virginia Ave

Building 4372

Fort Polk, LA 71459-5110

FOB: Destination

Total Cost: